Effects of protein coding polymorphisms in the kallikrein 1 gene on baseline blood pressure and antihypertensive response to irbesartan in Chinese hypertensive patients
Authors:
Open Access
- 8 July 2010
- journal article
- research article
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 25 (5) , 327-333
Abstract
The aim of this study was to determine the association between coding variants in the human tissue kallikrein 1 (KLK1) gene and baseline blood pressure (BP) and antihypertensive response to irbesartan treatment in Chinese hypertensive patients. A total of 1061 hypertensives were recruited and received daily oral dosage of 150 mg irbesartan for 4 weeks. Predose BPs, BPs and blood irbesartan concentrations at postdose on the 28th day were all measured. Common functional single-nucleotide polymorphisms (SNPs) in the KLK1 gene were genotyped. On the basis of the HapMap data of Han Chinese in the Beijing population, two non-synonymous polymorphisms with minor allele frequency>0.1, SNP rs5517 (Glu162Lys) and rs5516 (Gln121Glu), were selected. Those with GG genotype in the rs5516 locus had higher average baseline systolic BP (SBP) than CC subjects (β±s.e.: 5.0±2.3, P=0.033); and no associations of rs5517 with baseline BP (diastolic BP (DBP) and SBP) and BP responses, or rs5516 with baseline DBP and BP response were observed. In a haplotype-based association test for the KLK1 gene, the Haplo-special score analyses identified that haplotype AG was marginally associated with SBP response (specific score: 1.75 for P=0.08), but not with DBP response. We did not find any associations between haplotypes (GC and AC) and BP responses. The Haplo-GLM analyses showed that, compared with haplotype GC subjects, the subjects with haplotype AG had a marginally greater SBP response (adjusted β±s.e.: 1.81±0.97, P=0.06), but DBP response did not differ. This study suggests that rs5516 in the KLK1 gene may be involved in the development of essential hypertension and in the regulation of SBP-lowering response to irbesartan in Chinese hypertensives.Keywords
This publication has 30 references indexed in Scilit:
- Individual and joint association of α-adrenergic receptor Arg347Cys polymorphism and plasma irbesartan concentration with blood pressure therapeutic response in Chinese hypertensive subjectsClinical Pharmacology & Therapeutics, 2005
- IrbesartanDrugs, 2004
- Allelic discrimination using fluorogenic probes and the 5′ nuclease assayGenetic Analysis: Biomolecular Engineering, 1999
- Dose-Related Efficacy of Irbesartan for HypertensionHypertension, 1998
- ValsartanDrugs, 1997
- Paracrine Systems in the Cardioprotective Effect of Angiotensin-Converting Enzyme Inhibitors on Myocardial Ischemia/Reperfusion Injury in RatsHypertension, 1996
- Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.Journal of Clinical Investigation, 1995
- Human tissue kallikrein induces hypotension in transgenic mice.Hypertension, 1994
- A gene for high urinary kallikrein may protect against hypertension in Utah kindreds.Hypertension, 1989
- Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight-year follow-up.Circulation, 1978